A brand new treatment for advanced prostate cancer has been given the green light to be used in Scotland, helping doctors fight the disease in a new way.
The Scottish Medicines Consortium (SMC) have approved the use of a novel hormonal therapy for men with metastatic hormone-sensitive prostate cancer, reports the Daily Record.
Joseph Woollcott, policy and health influencing manager at Prostate Cancer UK, said: "We are pleased by this decision, which will give men with advanced prostate cancer another life-extending treatment option.